TODD BROOKS: Open Payments
NPI 1598292724 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,602 in 97 payments from 12 companies in 2025. Trend: 2023 $2,345 · 2024 $2,335 · 2025 $1,602
Food & beverage: $1,502Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 31 | $522 |
| GENZYME CORPORATION | 14 | $272 |
| Lilly USA, LLC | 14 | $224 |
| ABBVIE INC. | 19 | $213 |
| Amgen Inc. | 5 | $96 |
| Regeneron Healthcare Solutions, Inc. | 4 | $84 |
| UCB, Inc. | 3 | $54 |
| Incyte Corporation | 2 | $42 |
| Arcutis Biotherapeutics, Inc. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
Products named: TREMFYA, DUPIXENT, TALTZ, SKYRIZI, OTEZLA, Bimzelx, RINVOQ, EBGLYSS.
Industry payments across CA — which companies pay providers there.
